The digital healthcare landscape faced a harsh reality check on February 6, 2026, as shares of Doximity, Inc. (NYSE: DOCS) plummeted 17% in early trading. Despite reporting fiscal third-quarter results that surpassed analyst estimates for both revenue and earnings, the professional network for physicians issued a tepid outlook for the
Multiple brokerages cut their price target on the stock after Doximity reported a fall in third-quarter earnings and a soft fourth-quarter revenue outlook.
Medical professional network Doximity (NYSE:DOCS) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 9.8% year on year to $185.1 million. On the other hand, next quarter’s revenue guidance of $143.5 million was less impressive, coming in 5.2% below analysts’ estimates. Its non-GAAP profit of $0.46 per share was 2.9% above analysts’ consensus estimates.
Medical professional network Doximity (NYSE:DOCS) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $185.1 million. On the other hand, next quarter’s revenue guidance of $143.5 million was less impressive, coming in 5.2% below analysts’ estimates. Its non-GAAP profit of $0.46 per share was 2.9% above analysts’ consensus estimates.
A number of stocks fell in the afternoon session after the "AI replacement" narrative reached a fever pitch following the release of new models from Anthropic and OpenAI.
A number of stocks fell in the afternoon session after fears of disruption from artificial intelligence spooked investors, leading to a broad-based sell-off. The market witnessed a "basket-style reaction," a term for when investors reduce exposure to an entire segment without differentiating between individual company business models. The negative sentiment was widespread, pulling down all of the Magnificent Seven stocks and sending the S&P 500 Information Technology Sector down nearly 3%.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
What a brutal six months it’s been for Doximity. The stock has dropped 35% and now trades at $40.32, rattling many shareholders. This might have investors contemplating their next move.
A number of stocks fell in the afternoon session after tech stocks pulled back as reports surfaced that Chinese customs authorities blocked Nvidia's H200 AI chips, effectively halting their entry despite recent U.S. export approvals.
The digital health landscape faced a sobering milestone this week as shares of Doximity, Inc. (NYSE: DOCS), the leading professional network for physicians, plummeted to a new 52-week low. On January 12, 2026, the stock touched $43.21, marking a dramatic retreat from its February 2025 peak of $85.21.
A number of stocks fell in the morning session after a broader market rotation out of the technology sector led to profit-taking following a recent rally.
Looking back on vertical software stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers.
A number of stocks jumped in the afternoon session after investors wagered geopolitical tension would be contained following the U.S. military's operation in Venezuela, with the Dow hitting a fresh record.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
